Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Expanded Access
CLA
1 other identifier
expanded_access
N/A
1 country
1
Brief Summary
Expanded access to DCA as continued treatment for congenital lactic acidosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2013
CompletedFirst Posted
Study publicly available on registry
February 22, 2013
CompletedAugust 8, 2017
August 1, 2017
February 15, 2013
August 7, 2017
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of congenital lactic acidosis
You may not qualify if:
- Intolerance to DCA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida Box 100226
Gainesville, Florida, 32610-0226, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter W. Stacpoole, PhD, MD
University of Florida
Study Design
- Study Type
- expanded access
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2013
First Posted
February 22, 2013
Last Updated
August 8, 2017
Record last verified: 2017-08